Neurology News

Early-life exposure to screens and digital media was associated with higher odds of atypical sensory processing in a study of nearly 1,500 children, researchers reported in JAMA Pediatrics.

A biopharma company has received approval from the European Medicines Agency to commence a phase 1 clinical trial of its selective endocannabinoid reuptake inhibitor, which aims to restore healthy brain physiology.

The FDA has granted fast track designation for an autologous, fully human CD19 chimeric antigen receptor T-cell product candidate to treat those with refractory progressive multiple sclerosis, according to the manufacturer.

A Houston-area biotech company will expand indications of its investigational and proprietary biologic combination therapy beyond amyotrophic lateral sclerosis to include frontotemporal dementia and Parkinson’s disease.

The FDA has approved expanded MRI labeling for Abbott’s dorsal root ganglion stimulation therapy, which allows those with complex regional pain syndrome to receive full-body MRI scans while implanted with the device.

More older patients with COPD, dementia or kidney failure had a palliative care consultation shortly after admission through a default ordering system vs. usual care, according to study results published in JAMA.

A novel smartphone app was shown to diagnose vestibular stroke symptoms via tracked eye movements in healthy volunteers with an accuracy similar to current clinical standard devices, researchers reported.

IGC Pharma has announced that dosing has commenced at one of its sites participating in a phase 2b clinical trial of a combination therapy for agitation in dementia related to Alzheimer’s disease.

The FDA has cleared an investigational new drug application for an unmodified neural-derived exosome to treat those with acute ischemic stroke, according to its manufacturer.

Daily multivitamin supplementation was linked to benefits in both memory and cognition, according to a study published in the American Journal of Clinical Nutrition.